Supporting India during the devastating coronavirus surge

Megan Van Etten
Megan Van Etten May 20, 2021

Supporting India during the devastating coronavirus surge.

Share This

Like many others around the world, America’s biopharmaceutical companies stand with those affected by the coronavirus. And while biopharmaceutical companies are working around the clock to meet the demands of COVID-19 by developing and delivering therapeutics and vaccines, we recognize that the coronavirus crisis in India requires urgent attention and collaborative solutions from stakeholders globally. 

The devastating COVID-19 surge in the country set daily records for its toll. As of early May, daily cases topped 400,000 – totaling more than 25 million Indians affected as of May 19th – including hundreds of thousands of deaths. As global innovators and manufacturers, we know the biopharmaceutical industry has a critical role to play. Here are some ways we are trying to alleviate the burden of COVID-19 in India:

Beating this global health crisis requires ongoing perseverance, collaboration and innovation. And our work will continue until the pandemic is defeated worldwide.

To see PhRMA’s fact sheet on the efforts of our member companies to support India, please click here. And to get the latest updates and learn more about the biopharmaceutical industry’s work to beat COVID-19, please visit phrma.org/coronavirus.

Topics: Vaccines, Coronavirus